Ozempic (semaglutide)

Ozempic is a weekly injection product containing semaglutide, made by Novo Nordisk. Its approved use in the U.S. is type 2 diabetes.

FDA-approved, but not for obesity

Educational information. This page does not give dosing instructions or tell you what to take. The current label and a prescriber decide that.

What Ozempic is

Generic name
Semaglutide
Maker
Novo Nordisk
Form
Weekly injection
U.S. approved use
Type 2 diabetes
First U.S. approval
2017

How it differs from related products

Ozempic contains semaglutide, the same drug as Wegovy, and is also a weekly injection. Its approved use is type 2 diabetes, not weight management. A prescriber using a diabetes-approved product to treat weight is using it off-label. This atlas does not advise on that.

ProductFormU.S. approved useStatus
WegovyWeekly injectionWeight managementFDA-approved for weight management
Wegovy HDWeekly injection (higher strength)Weight managementFDA-approved for weight management
Wegovy pillDaily tabletWeight managementFDA-approved for weight management
Ozempic (this page)Weekly injectionType 2 diabetesFDA-approved, but not for obesity
RybelsusDaily tabletType 2 diabetesFDA-approved, but not for obesity

What it is approved for

Type 2 diabetes. The current label lists the exact approved uses.

A prescriber using a diabetes-approved product to treat weight is using it off-label. This atlas does not advise on that, and its weight-loss figures are not from studies of this product.

How it is taken

Weekly injection. Follow the current label and your prescriber for how to use it.

What the trials found

The weight-loss trial figures in this atlas come from studies of the weight-management products. They are not shown here because they were not studies of Ozempic's approved use.

Safety

Warnings, side effects and open questions for semaglutide are on the semaglutide page. The official label is the controlling source.

Compiled from public information: FDA-approved labels, manufacturer websites, ClinicalTrials.gov and published journal articles. Sources are listed at the bottom of this page.

Related

Sources

  1. Ozempic (semaglutide) injection: prescribing information Novo Nordisk, on DailyMed (U.S. National Library of Medicine). Label version 6/2026. Official FDA label on DailyMed
  2. DailyMed: current FDA drug labels U.S. National Library of Medicine. Regulator
  3. Drugs@FDA: approved drug products U.S. Food and Drug Administration. Regulator